Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 6
2005 4
2006 5
2007 14
2008 17
2009 10
2010 22
2011 37
2012 36
2013 56
2014 61
2015 64
2016 55
2017 59
2018 49
2019 57
2020 86
2021 78
2022 92
2023 88
2024 98
2025 63

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

916 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.
Kaul I, Sawchak S, Correll CU, Kakar R, Breier A, Zhu H, Miller AC, Paul SM, Brannan SK. Kaul I, et al. Among authors: correll cu. Lancet. 2024 Jan 13;403(10422):160-170. doi: 10.1016/S0140-6736(23)02190-6. Epub 2023 Dec 14. Lancet. 2024. PMID: 38104575 Clinical Trial.
What is good mental health? A scoping review.
Fusar-Poli P, Salazar de Pablo G, De Micheli A, Nieman DH, Correll CU, Kessing LV, Pfennig A, Bechdolf A, Borgwardt S, Arango C, van Amelsvoort T. Fusar-Poli P, et al. Among authors: correll cu. Eur Neuropsychopharmacol. 2020 Feb;31:33-46. doi: 10.1016/j.euroneuro.2019.12.105. Epub 2019 Dec 31. Eur Neuropsychopharmacol. 2020. PMID: 31901337 Free article.
Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019.
Solmi M, Seitidis G, Mavridis D, Correll CU, Dragioti E, Guimond S, Tuominen L, Dargél A, Carvalho AF, Fornaro M, Maes M, Monaco F, Song M, Il Shin J, Cortese S. Solmi M, et al. Among authors: correll cu. Mol Psychiatry. 2023 Dec;28(12):5319-5327. doi: 10.1038/s41380-023-02138-4. Epub 2023 Jul 27. Mol Psychiatry. 2023. PMID: 37500825
Towards a youth mental health paradigm: a perspective and roadmap.
Uhlhaas PJ, Davey CG, Mehta UM, Shah J, Torous J, Allen NB, Avenevoli S, Bella-Awusah T, Chanen A, Chen EYH, Correll CU, Do KQ, Fisher HL, Frangou S, Hickie IB, Keshavan MS, Konrad K, Lee FS, Liu CH, Luna B, McGorry PD, Meyer-Lindenberg A, Nordentoft M, Öngür D, Patton GC, Paus T, Reininghaus U, Sawa A, Schoenbaum M, Schumann G, Srihari VH, Susser E, Verma SK, Woo TW, Yang LH, Yung AR, Wood SJ. Uhlhaas PJ, et al. Among authors: correll cu. Mol Psychiatry. 2023 Aug;28(8):3171-3181. doi: 10.1038/s41380-023-02202-z. Epub 2023 Aug 14. Mol Psychiatry. 2023. PMID: 37580524 Free PMC article. Review.
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
Solmi M, De Toffol M, Kim JY, Choi MJ, Stubbs B, Thompson T, Firth J, Miola A, Croatto G, Baggio F, Michelon S, Ballan L, Gerdle B, Monaco F, Simonato P, Scocco P, Ricca V, Castellini G, Fornaro M, Murru A, Vieta E, Fusar-Poli P, Barbui C, Ioannidis JPA, Carvalho AF, Radua J, Correll CU, Cortese S, Murray RM, Castle D, Shin JI, Dragioti E. Solmi M, et al. Among authors: correll cu. BMJ. 2023 Aug 30;382:e072348. doi: 10.1136/bmj-2022-072348. BMJ. 2023. PMID: 37648266 Free PMC article.
Psychopharmacology in children and adolescents: unmet needs and opportunities.
Cortese S, Purper-Ouakil D, Apter A, Arango C, Baeza I, Banaschewski T, Buitelaar J, Castro-Fornieles J, Coghill D, Cohen D, Correll CU, Grünblatt E, Hoekstra PJ, James A, Jeppesen P, Nagy P, Pagsberg AK, Parellada M, Persico AM, Roessner V, Santosh P, Simonoff E, Stevanovic D, Stringaris A, Vitiello B, Walitza S, Weizman A, Wong ICK, Zalsman G, Zuddas A, Carucci S, Butlen-Ducuing F, Tome M, Bea M, Getin C, Hovén N, Konradsson-Geuken A, Lamirell D, Olisa N, Nafria Escalera B, Moreno C. Cortese S, et al. Among authors: correll cu. Lancet Psychiatry. 2024 Feb;11(2):143-154. doi: 10.1016/S2215-0366(23)00345-0. Epub 2023 Dec 7. Lancet Psychiatry. 2024. PMID: 38071998 Review.
Treatment resistance in schizophrenia: a meta-analysis of prevalence and correlates.
Diniz E, Fonseca L, Rocha D, Trevizol A, Cerqueira R, Ortiz B, Brunoni AR, Bressan R, Correll CU, Gadelha A. Diniz E, et al. Among authors: correll cu. Braz J Psychiatry. 2023 Sep-Oct;45(5):448-458. doi: 10.47626/1516-4446-2023-3126. Epub 2023 Sep 17. Braz J Psychiatry. 2023. PMID: 37718484 Free PMC article.
916 results